RELATED RESOURCES
PrintKey Statistics: HTEC
ROBO GLOBAL HEALTHCARE TECHNOLOGY & INNOVATION ETF
47.50
-0.69 (-1.4318%)
as of 4:10:00pm ET 01/27/2021
Quotes delayed at least 15 min.
Log in for real time quote.
Basic Facts |
|||
|---|---|---|---|
| ETP Type | ETF | Sponsor | Exchange Traded Concepts, LLC |
| Legal Structure | Open-End Investment Company | Inception Date | 06/24/2019 |
| Schedule K-1 | -- | Options | No |
| Leveraged | No | Management Team | 2 Managers |
| Inverse | No | ||
Show BioPortfolio Fundamentals
| Valuation Info | HTEC | Asset Class Median | Percentile in Asset Class | |
|---|---|---|---|---|
| Tracking Error | 10.32 | 11.92 |
|
60th |
| Annual Turnover Ratio | 20.00% | 29.00% |
|
67th |
| Efficiency | -2.06 | -0.96 |
|
41st |
| Tax Cost Ratio | 0.00% | 0.64% |
|
100th |
| Equity: Price/Trailing Earnings | 32.99 | 22.20 |
|
12nd |
| Equity: Price/Book | 6.59 | 2.46 |
|
10th |
| Equity: Price/Sales | 7.05 | 1.83 |
|
4th |
| Equity: Price/Cash Flow | 28.56 | 11.47 |
|
3rd |
| 30-day SEC Yield AS OF 12/31/2020 |
0.00% | 1.24% |
|
-- |
| Dividend Yield (Annualized) | -- | n/a | n/a | |
| Net Expense Ratio | 0.68% | 0.5% |
|
28th |
| Gross Expense Ratio | 0.80% | 0.51% |
|
22nd |
| Equity: Historical Earnings Growth % | -- | +14.91% |
|
-- |
| Equity: Sales Growth % | +9.24% | +5.70% |
|
86th |
| Equity: Cash Flow Growth % | +14.54% | +6.71% |
|
91st |
| Equity: Book-Value Growth % | +10.60% | +5.60% |
|
90th |
| Net Assets | $124.6M | $123.3M |
|
51st |
Trading Statistics
| Valuation Info | HTEC | Asset Class Median | Percentile in Asset Class | |
|---|---|---|---|---|
| Median Bid/Ask Spread (30 Day) | 0.12% | 0.16% |
|
64th |
| Premium/Discount (1 Month Rolling Average) | 0.05% | 0.00% |
|
78th |
| Premium/Discount (1 Year Average) | 0.11% | -0.03% |
|
36th |
| Volume | 252.4K | 21.0K |
|
78th |
| Volume (Today/Avg 10 Day) | 3.1 | 0.7 |
|
94th |
| Volume (10 Day Average) | 82.5K | 26.7K |
|
68th |
| Volume (30 Day Average) | 65.9K | 26.4K |
|
65th |
| Volume (90 Day Average) | 46.7K | 26.2K |
|
60th |
| Volume (10 Day Avg/90 Day Avg) | 1.8 | 1.1 |
|
84th |
| Shares Outstanding | 3.5M | 2.8M |
|
54th |
The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.
FBS receives compensation from the funds advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETFs prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.
